Search results for: Pricing and Reimbursement
Filter search results
OHE Launches Discussion Paper and Consultation Exercise on Indication-based Pricing
10 May 2019
…Pricing in the US and Five Major European Countries . Consulting Report, Office of Health Economics. Neri, M., Towse, A., and Garau, M., 2018. Multi-Indication Pricing (MIP): Practical Solutions and…
Is It Time to Reconsider the Role of Co-Payments in Europe?
11 January 2012
…of Health Economics. 13(1), 1-5. [2] Espin, J. and Rovira, J. (2007) Analysis of differences and commonalities in pricing and reimbursement systems in Europe. Final Report. Brussels: European Commission. …
Assessing the Life-cycle Value of Second-generation Antipsychotics in Sweden and the UK
17 July 2019
…that pricing and reimbursement decisions should consider how to recognise the dynamic nature of pharmaceutical markets and the full life cycle of value added by innovative medicines. This presents a…
Industrial Policy and the Pharmaceutical Industry
1 January 1995
…government science and education policy for the discovery and development process. The seventh and eighth papers by Quam and Professor Grabowski respectively explore the role of government as purchaser and…
Partnerships for Health System Innovation and Improvement
12 September 2023, 3:00pm
…research interests include the evaluation of interventions and policies that improve health system’s resilience and performance in the face of scarce resources and high pressure. She has worked on methods…
Making Outcome-Based Payment a Reality in the NHS
2 January 2019
…both qualitative and quantitative analysis, using a combination of literature reviews, interviews with key stakeholders, and engagement with patients and carers through focus groups and a survey. This report is…
Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Five Questions We Think Matter a Lot
29 March 2019
…and protect against collusion. Spending on pharmaceuticals and other healthcare commodities is high and makes up a large proportion of healthcare spending in rich and poorer markets alike. In this,…
OHE at ISPOR May 2016: Meet the Team
19 May 2016
…Multi-Indication Pricing: Pros, Cons and its Applicability to the UK OHE Authors: Jorge Mestre-Ferrandiz and Adrian Towse Time and date: Monday 23rd May, 3:45pm. Summary: Multi-indication pricing (MIP) involves setting…
How Have HTA Agencies Evolved Their Methods Over Time?
29 April 2024
…outcomes, and time horizons. However, some of them have different discount rates for costs and benefits, and for others, the discount rates decline with a longer time horizon. Figure 1…